Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced that Joydeep Goswami has decided to leave Illumina. He will stay on in an advisory role through June 30 to support two new executive management team appointments. Ankur Dhingra is joining Illumina as Chief Financial Officer (CFO), leading Illumina’s financial planning and analysis, accounting, investor relations, internal audit,…
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief Executive Officer, effective September 25, 2023. Thaysen’s extensive background and experience in genomics, life sciences, and technology…
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the opening of a new office and state-of-the-art Illumina Solutions Center in Bengaluru, India. Illumina’s expansion comes after 16 years of working closely with the company’s channel partner in India, Premas Life Sciences. Now with its own permanent facility, Illumina will continue to collaborate with…
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina’s Chief Executive Officer and as a Director, effective Sunday, June 11. Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of Directors conducts…
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced Joydeep Goswami has been appointed Chief Financial Officer, effective immediately. Goswami previously served as Illumina’s Chief Strategy and Corporate Development Officer and interim Chief Financial Officer. As CFO, Goswami will be responsible for the Company’s financial planning and analysis, accounting, investor relations, internal audit, tax,…
Illumina, Inc., a DNA sequencing company, announced Joydeep Goswami, Chief Strategy and Corporate Development Officer, will also serve as interim Chief Financial Officer while the company conducts a search for a permanent CFO. Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years. In addition to Goswami’s current responsibilities, which…
Illumina and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit percentage…